Get a deeper insight into the potential performance of Axon (AXON) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Besides Wall Street's top-and-bottom-line estimates for Illumina (ILMN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.

Get a deeper insight into the potential performance of Vertex (VRTX) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Besides Wall Street's top-and-bottom-line estimates for Kimco Realty (KIM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for MasTec (MTZ), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.

On 8/1/25, NRG Energy, Emera, and Pinnacle West Capital will all trade ex-dividend for their respective upcoming dividends. NRG Energy will pay its quarterly dividend of $0.44 on 8/15/25, Emera will pay its quarterly dividend of $0.725 on 8/15/25, and Pinnacle West Capital will pay its quarterly dividend of $0.895 on 9/2/25.

Bristol Myers Squibb (NYSE:BMY) is scheduled to release its earnings report on Thursday, July 31, 2025. For event-driven traders, examining historical stock performance around earnings announcements can provide valuable insights.

NMIH tops Q2 estimates as higher premiums and investment income offset lower persistency and rising claims.

LCID is expected to top Q2 estimates as record deliveries, rising production and Gravity SUV generate fuel optimism.

PPG meets Q2 earnings estimates despite a 1% revenue dip, with Performance Coatings hitting record sales.

Ardmore Shipping (ASC) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $1.13 per share a year ago.

LENZ Therapeutics, Inc. (LENZ) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to a loss of $0.4 per share a year ago.

Spanish telecom giant Telefonica is replacing all of its 5G equipment made by Chinese manufacturer Huawei in Spain and Germany to comply with local rules, but it intends to keep it in Brazil.

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

Lithia Motors tops Q2 estimates as strong used vehicle pricing and aftersales growth offset lower-than-expected new vehicle sales.

MAYFIELD VILLAGE, OHIO, July 30, 2025 (GLOBE NEWSWIRE) -- As previously announced, The Progressive Corporation (NYSE: PGR) will host an Investor Relations event on Tuesday, August 5, 2025, beginning at 9:30 a.m. eastern time. This event, which will consist of both a conference call and webcast, is scheduled to last 90 minutes and will begin with an approximate 45-minute presentation on our pricing methodology, followed by a question-and-answer session with Tricia Griffith, our CEO, and John Sauerland, our CFO. Call-in participants will be able to ask questions via phone, however, webcast participants will not be able to submit questions online.

9:55am: Cautious start Markets opened little changed on Wednesday as investors took in a stronger-than-expected rebound in economic growth and braced for a key Federal Reserve interest rate decision later in the day. The Dow Jones was flat, up just 3 points to 44,636, while the S&P 500 edged up 5 points, or 0.1%, to 6,376.

Meta will report earnings for the second quarter after the closing bell on Wednesday. Wall Street expects $44.3 billion in revenue for the quarter.

GlobalFoundries Inc. is becoming the face of chip-making in the U.S., but we think it has high exposure to weakening smart mobile device business line. Onshoring momentum and U.S. foundry status offer long-term potential, but financial benefits will take time to materialize. We think GlobalFoundries has its work cut out for it and don't see a convincing enough near-term catalyst to upgrade GFS stock to a Buy ahead of Q2 earnings results.

The three stocks in this analysis all have earnings calls after the bell, which is after the Federal Reserve releases its latest interest rate decision, statement, and follow up press conference.